Search hospitals

>

Quebec

>

MONTREAL

Centre Hospitalier Universitaire Sainte-Justine

Claim this profile

MONTREAL, Quebec H3T 1C5

Global Leader in Brain Tumor

Global Leader in Solid Tumors

Conducts research for Cancer

Conducts research for Leukemia

Conducts research for Acute Lymphoblastic Leukemia

468 reported clinical trials

41 medical researchers

Photo of Centre Hospitalier Universitaire Sainte-Justine in MONTREALPhoto of Centre Hospitalier Universitaire Sainte-Justine in MONTREALPhoto of Centre Hospitalier Universitaire Sainte-Justine in MONTREAL

Summary

Centre Hospitalier Universitaire Sainte-Justine is a medical facility located in MONTREAL, Quebec. This center is recognized for care of Brain Tumor, Solid Tumors, Cancer, Leukemia, Acute Lymphoblastic Leukemia and other specialties. Centre Hospitalier Universitaire Sainte-Justine is involved with conducting 468 clinical trials across 826 conditions. There are 41 research doctors associated with this hospital, such as Yvan Samson, Monia Marzouki, Jocelyn Gravel, MD, and Colette Deslandres.

Area of expertise

1

Brain Tumor

Global Leader

Centre Hospitalier Universitaire Sainte-Justine has run 55 trials for Brain Tumor. Some of their research focus areas include:

Stage I
Stage II
Stage IV
2

Solid Tumors

Global Leader

Centre Hospitalier Universitaire Sainte-Justine has run 51 trials for Solid Tumors. Some of their research focus areas include:

Stage IV
BRAF positive
MYC negative

Top PIs

Clinical Trials running at Centre Hospitalier Universitaire Sainte-Justine

Brain Tumor

Testicular cancer

Wilms Tumor

Prader-Willi Syndrome

Cancer

Retinoblastoma

Langerhans Cell Histiocytosis

Proteinuria

Chronic Kidney Disease

Low Grade Glioma

Image of trial facility.

Selumetinib vs. Chemotherapy

for Brain Cancer

This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.

Recruiting

2 awards

Phase 3

Image of trial facility.

Lower Radiotherapy Dose

for Brain Tumors

This phase II trial studies how well lower dose radiotherapy after chemotherapy (Carboplatin \& Etoposide) works in treating children with central nervous system (CNS) germinomas. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. Researchers want to see if lowering the dose of standard radiotherapy (RT) after chemotherapy can help get rid of CNS germinomas with fewer long-term side effects.

Recruiting

1 award

Phase 2

10 criteria

Image of trial facility.

Health Information Collection

for Childhood Cancer

This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

Recruiting

1 award

N/A

10 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Centre Hospitalier Universitaire Sainte-Justine?

Where is Centre Hospitalier Universitaire Sainte-Justine located?

Who should I call to ask about financial aid or insurance network?

What insurance does Centre Hospitalier Universitaire Sainte-Justine accept?

What awards or recognition has Centre Hospitalier Universitaire Sainte-Justine received?